For more information on Recombinetics Chapter 11 Restructuring please click here
One Platform, all Industries.
Groundbreaking Technology for Animal Ag and Biomedicine
Recombinetics’ gene editing platform is the foundation of our BioVentures and core services studio. Our BioVentures arise from in-house and externally developed opportunities that depend on gene edited large animals to disrupt their industries. We also mobilize the platform by offering preclinical services in custom gene edited models that can supplement or reduce the reliance on nonhuman primates in preclinical research.
FACING THE FACTS
> 3,000
clinical trials for cell and gene therapies in past 5 years
90%
of all clinical trials fail
1.5 BILLION
Smallholders need more efficient animals to produce healthy protein
notable news
Swine Reporter Models For Somatic Cell Gene Editing
We’re in Baltimore for ASGCT 2024! Stop by poster #517 on Wednesday, May 8th at 5:30 EST to hear from Jarryd Campbell about our swine reporter models for somatic cell genome editing. We are looking forward to making some new connections and meeting up with old colleagues.